Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 106,728 | 103,744 | 86,295 | 78,868 | 84,586 |
| Receivables | 115,141 | 118,782 | 115,253 | 111,498 | 112,053 |
| Inventories | 124,488 | 122,924 | 123,575 | 115,926 | 112,907 |
| Income taxes - deferred | 23,377 | 22,710 | 20,915 | 21,477 | 24,207 |
| Other current assets | 15,993 | 16,177 | 21,745 | 28,121 | 19,624 |
| TOTAL | $385,727 | $384,337 | $367,783 | $355,890 | $353,377 |
| Non-Current Assets | |||||
| PPE Net | 196,542 | 189,660 | 186,708 | 189,646 | 178,655 |
| Intangibles | 0 | 0 | 0 | 207,095 | 0 |
| Other Non-Current Assets | 232,620 | 224,513 | 216,013 | 12,806 | 246,661 |
| TOTAL | $429,162 | $414,173 | $402,721 | $409,547 | $425,316 |
| Total Assets | $814,889 | $798,510 | $770,504 | $765,437 | $778,693 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 801 | 788 | 777 | 765 | 754 |
| Accounts payable and accrued liabilities | 21,465 | 26,472 | 23,541 | 28,006 | 0 |
| Accrued Expenses | 96,460 | 89,225 | 73,726 | 91,292 | 91,227 |
| TOTAL | $198,563 | $213,110 | $292,143 | $295,292 | $307,750 |
| Non-Current Liabilities | |||||
| Long Term Debt | 84,489 | 84,694 | 4,896 | 5,094 | 5,157 |
| Deferred Revenues | 10,994 | 10,834 | 10,831 | 11,285 | 10,458 |
| Other Non-Current Liabilities | 12,272 | 12,429 | 11,476 | 11,137 | 11,527 |
| TOTAL | $116,692 | $114,826 | $32,533 | $31,951 | $33,616 |
| Total Liabilities | $315,255 | $327,936 | $324,676 | $327,243 | $341,366 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 117,184 | 117,196 | 118,026 | 118,258 | 119,120 |
| Common Shares | 9,616 | 9,583 | 9,563 | 9,539 | 9,531 |
| Retained earnings | 793,305 | 761,769 | 728,102 | 702,031 | 678,476 |
| Other shareholders' equity | 13,123 | 8,768 | 717 | 8,932 | 25,243 |
| TOTAL | $499,634 | $470,574 | $445,828 | $438,194 | $437,327 |
| Total Liabilities And Equity | $814,889 | $798,510 | $770,504 | $765,437 | $778,693 |